Tenax Therapeutics (TENX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Operating Expenses | 4,619 | 3,671 | 3,909 | 3,341 | 2,117 |
| Operating Income | -4,619 | -3,671 | -3,909 | -3,341 | -2,117 |
| Interest Expense | 7 | 9 | 8 | 2 | 5 |
| Other Income | 665 | 105 | 118 | 117 | 151 |
| Pre-tax Income | -3,961 | -3,575 | -3,799 | -3,226 | -1,972 |
| Net Income Continuous | -3,961 | -3,575 | -3,799 | -3,226 | -1,972 |
| Net Income | $-3,961 | $-3,575 | $-3,799 | $-3,226 | $-1,972 |
| EPS Basic Total Ops | -0.19 | -1.83 | -3.12 | -8.33 | -6.61 |
| EPS Basic Continuous Ops | -0.19 | -1.83 | -3.12 | -8.35 | -6.61 |
| EPS Diluted Total Ops | -0.19 | -1.83 | -3.12 | -8.33 | -6.61 |
| EPS Diluted Continuous Ops | -0.19 | -1.83 | -3.12 | -8.35 | -6.61 |
| EPS Diluted Before Non-Recurring Items | -0.19 | -1.83 | -3.12 | N/A | N/A |
| EBITDA(a) | $-4,619 | $-3,671 | $-3,909 | $-3,336 | $-2,116 |